Integer (ITGR) announced the completion of the previously announced sale of its Electrochem business to Ultralife (ULBI) for $50 million in cash. Integer will use the proceeds from the sale to pay down outstanding debt.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ITGR:
- Integer price target raised to $140 from $125 at Piper Sandler
- Integer Holdings Announces Leadership Changes and Strong Q3 Results
- Integer names Payman Khales COO, Andrew Senn president, Cardio & Vascular
- Integer reports Q3 adjusted EPS $1.43, consensus $1.36
- Integer raises sees FY24 adjusted EPS $5.24-$5.43, consensus $5.30